U S Food and Drug Administration Home Page

- FDA issues new plan on medical device safety
- Medical Device Safety Action Plan provides modernized vision for protecting patients, spurring innovation of new products
- FDA issues new plan on medical device safety
- FDA issues guidance on caffeine supplements
- Agency takes important step to protect consumers against supplements containing dangerously high levels of caffeine
- FDA issues guidance on caffeine supplements
- Compounding and 503B Bulk Drug Substances
- FDA issues draft guidance on developing bulks drugs substances list for outsourcing facilities
- Compounding and 503B Bulk Drug Substances

Newsroom Meetings Testimonies Speeches

Newsroom

For Consumers
Updates and information for staying safe and healthy
For Patients
Learn about other treatments, drug/device approvals, public meetings and more
For Health Professionals
Medical product safety information, adverse event/problem reporting and more
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more
For Industry
Guidance, registration and listing, pay user fees, import programs and more

FDA issues new plan on medical device safety